Memphis Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Memphis Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP148.1M and total debt of EGP152.5M, which brings its debt-to-equity ratio to 102.9%. Its total assets and total liabilities are EGP1.0B and EGP856.0M respectively. Memphis Pharmaceuticals & Chemical Industries's EBIT is EGP155.7M making its interest coverage ratio -6.8. It has cash and short-term investments of EGP522.5M.
Key information
102.9%
Debt to equity ratio
ج.م152.47m
Debt
| Interest coverage ratio | -6.8x |
| Cash | ج.م522.50m |
| Equity | ج.م148.12m |
| Total liabilities | ج.م856.04m |
| Total assets | ج.م1.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MPCI's short term assets (EGP917.7M) exceed its short term liabilities (EGP710.1M).
Long Term Liabilities: MPCI's short term assets (EGP917.7M) exceed its long term liabilities (EGP145.9M).
Debt to Equity History and Analysis
Debt Level: MPCI has more cash than its total debt.
Reducing Debt: MPCI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: MPCI's debt is well covered by operating cash flow (350.6%).
Interest Coverage: MPCI earns more interest than it pays, so coverage of interest payments is not a concern.